5:00 PM
|
Early Clinical Outcomes with the New Mentor Memory Gel Boost Implants: A Single-Surgeon’s Experience
Background:
The MENTOR MemoryGel BOOST (MGB) implant (Mentor Worldwide LLC, Irvine, CA), introduced in 2022, was engineered to improve breast augmentation and reconstruction outcomes by enhancing upper pole fullness and reducing rippling through its highly cohesive, precision-filled silicone gel fill.
Objectives:
This study aimed to assess the early clinical outcomes, safety profile, complication rates, and reoperation trends in patients undergoing primary and revision breast augmentation with MGB implants.
Methods:
A retrospective review was conducted of all patients who underwent primary (n=83) or revision (n=36) augmentation with MGB implants between March 2022 and January 2024 by a single senior surgeon. All patients had at least 6 months of follow-up. Demographics, implant characteristics, surgical techniques, and rates of postoperative complications were analyzed to assess device safety and efficacy. Kaplan-Meier curves estimated time-dependent risk-free survival from capsular contracture.
Results:
One hundred and nineteen total patients received MGB implants. Patients had a mean age of 38.9 years with an average follow-up of 418 ± 179 days. Inframammary incision (74%) and subfascial placement (77%) predominated. Average implant volume was 381cc, with 84% of patients selecting a Moderate Plus profile.
Complication rates were low: one superficial surgical-site infection (0.8%), and one Baker grade IV capsular contracture (0.8%), occurring in a former smoker. No hematoma, seroma, implant rupture, or rippling was observed during the study period. Reoperation occurred in 11 patients (9.2%), primarily for elective size increase (6.7%). One-year risk-free survival from capsular contracture was greater than 99%.
Conclusion:
In this early clinical outcomes review, MGB implants demonstrated promising short-term safety with exceptionally low rates of infection and capsular contracture, and no implant-specific failures. Reoperations were primarily patient-driven rather than complication-related. These data support MGB implants as a reliable and effective option for both primary and revision augmentation. Longer-term follow-up will be critical to confirm sustained performance.
|
5:05 PM
|
Acellular Dermal Matrix Mitigates Fibrotic Capsule Formation in a Mechanically Stimulated Tissue Expander Model
Purpose:
Tissue expanders are commonly used in two-stage implant-based breast reconstruction to gradually create space for a permanent implant by stretching the overlying soft tissue. To optimize outcomes, surgeons frequently place acellular dermal matrix (ADM) at the time of expander placement to provide inferolateral support, offload tension from mastectomy flaps, and reduce capsular fibrosis. Despite its widespread use, the mechanisms by which ADM modulates capsule formation in the setting of mechanical tissue expansion remain poorly defined. Furthermore, in clinical practice, expanders are initially filled with either air or saline, but the impact of the inflation medium on capsule formation remains unclear. We developed a clinically relevant murine tissue expander model incorporating sustained mechanical stimulation to compare air versus saline fill and to evaluate the mechanoprotective effect of ADM.
Methods:
Miniature smooth tissue expanders were combined with our mechanically stimulating implant (MSI) model to reliably induce clinically relevant, severe foreign body response (FBR)(1,2). Expanders were then filled with either air or saline, with parallel groups receiving ADM coverage, and implanted into the dorsal subcutaneous space of mice (n = 5/group). Capsule tissue was harvested on day 28. We quantified capsule thickness, collagen deposition, α-smooth muscle actin (α-SMA)–positive myofibroblasts, and immune cell infiltration, including CD45⁺ immune cells and F4/80⁺ macrophages.
Results:
Mechanical stimulation produced a robust and reproducible fibrotic capsule consistent with clinically observed fibrosis. Air and saline inflation yielded similar outcomes, with no significant differences in capsule thickness (p = 0.71-0.84), collagen content (p > 0.99), α-SMA⁺ cells (p > 0.99), CD45⁺ cell infiltration (p = 0.24-0.99), or F4/80⁺ macrophage density (p > 0.99). In both air and saline filled devices, ADM coverage significantly reduced capsule thickness (p < 0.005), collagen deposition (p < 0.001), α-SMA⁺ myofibroblasts (p < 0.05), CD45⁺ immune infiltrates (p < 0.001), and F4/80⁺ macrophages (p < 0.005) compared to expanders without ADM coverage.
Discussion:
We present the first murine tissue expander model that reliably induces mechanically driven capsule formation analogous to clinical FBR. Using this model, we found that air and saline inflation produce comparable levels of capsule formation. Notably, we found that ADM confers clear mechanoprotective effects by decreasing capsule fibrosis and inflammation. Although ADM has been clinically associated with improved outcomes, its biological mechanism has remained uncertain. This model provides direct experimental evidence that ADM attenuates the fibroinflammatory response generated during expansion. Our findings offer a mechanistic justification for incorporating ADM coverage at the time of tissue expander placement.
- Padmanabhan J, Chen K, Sivaraj D, et al. Allometrically scaling tissue forces drive pathological foreign-body responses to implants via Rac2-activated myeloid cells. Nat Biomed Eng. 2023;7(11):1419-1436.
- Sivaraj D, Padmanabhan J, Chen K, et al. IQGAP1-mediated mechanical signaling promotes the foreign body response to biomedical implants. FASEB J. 2022;36(2):e22007.
|
5:10 PM
|
Autocorrection of Hypertelorism and Aesthetic outcomes after spring mediated cranioplasty for metopic craniosynostosis
Background: Minimally invasive techniques for surgical correction of metopic craniosynostosis have grown in popularity. Minimally invasive techniques offer an improved safety profile and shorter operative duration while preserving cranial growth potential. Strip craniectomy with helmet therapy is associated with under correction and persistent supraorbital retrusion. Spring-mediated cranioplasty (SMC) is alternative technique, though data on outcomes remain limited. In this study, we present our institutional experience with SMC for metopic craniosynostosis.
Methods: A retrospective chart review was performed of patients who underwent SMC for metopic craniosynostosis between January 2015 and October 2025. Pre and post-operative ICD were measured on CT scans and 2D photographs. Intercanthal distance (ICD) was classified based on age-matched normative values. Threshold analysis was performed to identify spring force parameters associated with overcorrection.
Results: Twenty-three patients met inclusion criteria. One patient (4%) required a blood transfusion, and one patient (4%) required a revision for correction of head shape. Most (83%) patients received two springs, with a median total force of 18.6N and median force per spring of 9.3 N Transient hypertelorism occurred in 74% of patients, with 53% self-correcting at a median of 177 days. At final follow-up, 65% achieved normal ICD and 35% were hyperteloric. Threshold analysis revealed patients receiving >11N per spring had 12 times higher odds of persistent hypertelorism (p=0.033).
Conclusion: SMC is a safe and effective minimally invasive treatment for metopic craniosynostosis with low complication and revision rates. Higher spring forces may increase risk of persistent overcorrection, and these findings offer preliminary parameters to guide surgical planning.
|
5:15 PM
|
A Statistical Fragility Analysis of Randomized Controlled Trials on Biological Therapies in Diabetic Foot Ulcer Management
Purpose: With the global rise of diabetes, diabetic foot ulcers(DFUs) represent a leading cause of chronic, refractory wounds. While randomized controlled trials(RCTs) have evaluated biological substitutes for DFUs, reported clinical benefits remain inconsistent. Compared with the standard of care(SOC) – debridement, moist dressings, and pressure offloading – biologics introduce substantial costs. Importantly, statistical significance alone does not reflect the robustness of treatment effects. Thus, statistical fragility analysis can assess the strength of outcomes by quantifying how easily significance is overturned. This study aimed to evaluate the statistical fragility of RCT outcomes to determine whether biologics offer benefit over SOC in DFU management.
Methods: Following PRISMA guidelines, PubMed, Scopus, CENTRAL, and Web of Science were searched for RCTs evaluating biological substitutes for DFUs. Extracted outcomes included complete wound closure, adverse events, and recurrence. Fragility was assessed using Fisher's exact test with iterative changes to the proportion of outcome events. The fragility index(FI) represented the number of outcome changes needed to reverse statistical significance, while the reverse fragility index(rFI) measured the number needed to overturn nonsignificance. Fragility and reverse fragility quotients (FQ, rFQ) divide FI/rFI by the sample size to standardize outcomes, where an FQ of 0.05 indicates that five outcome changes per 100 patients would alter significance. Data was reported as Median(Q1-Q3).
Results: Thirty-three articles(N=3,459) were included, with 1,302 patients treated with dermal-matrices, 606 with placental membranes, 163 with epidermal-matrices, and 545 controls receiving SOC. Only 16(48.48%) trials performed power analyses, and a mean of 2.5(range: 0-24) patients per study were lost to follow-up. Biologics demonstrated superiority for wound closure in 13 of 23 trials, with a median FI of 6(3-8) and FQ of 0.082(0.024-0.130). Nonsignificant studies had median rFI of 4(3-4) and rFQ of 0.105(0.103-0.139). Meta-analysis favored dermal-matrices (OR[95% CI], 1.61[1.26-2.05], p<0.001; FI=56; FQ=0.047) and amniotic-membranes (1.95[1.53-2.49], p<0.001; FI=88; FQ=0.105) over SOC. Fragility quotients of amniotic membrane trials demonstrate comparatively greater robustness than dermal matrices. Studies directly comparing amniotic membranes and dermal matrices reported mixed, highly fragile wound-closure outcomes, with a mean FI of 3(2-4). Similarly, meta-analysis yielded comparable results(p=0.09; rFI=1; rFQ=0.005) with very high fragility. Adverse events were lower with biologics(26.4%) than SOC(35.5%, p<0.001), but results were not robust(FQ=0.024). No significant difference in disease recurrence was found between biologics and SOC(p=0.192, rFQ=0.036).
Conclusion: RCTs evaluating biologics for DFU treatment demonstrate considerable fragility of outcomes. Across all trials, reversal of statistical significance would occur if only 8.2% of patients treated with biologics failed to achieve wound closure. In multiple studies, FI values were lower than the number of patients lost to follow-up, further highlighting the potential vulnerability of trial findings. Although meta-analyses show improved wound healing with biologics, fragility analysis revealed minimal robustness, with ten or fewer outcome changes per 100 patients overturning significance. Even when comparing amniotic membranes and dermal matrices, data remains fragile, highlighting the need for stronger evidence comparing the cohorts. Given the global burden of diabetic foot ulcers and the considerable cost of biologics, adequately powered trials with robust statistical findings are essential for clinical adoption.
|
5:20 PM
|
A Structural Approach to Secondary Unilateral Cleft Rhinoplasty
Background: The secondary (mature) cleft nasal deformity poses a significant challenge for surgeons. Secondary cleft rhinoplasty is often performed with the goal of restoring nasal cosmesis and function. However, persistent deforming forces including cicatricial forces and cartilage memory can predispose patients to recurrent asymmetry, incomplete correction and relapse. We aimed to describe a comprehensive structural approach to secondary cleft rhinoplasty that prioritizes integrated stabilization of the central and lateral nasal framework and robust fixation of cartilage constructs. Key elements include a caudal septal extension fixated to the maxilla in the true facial midline, circumferential graft support of the cleft ala, dome and soft triangle to achieve symmetric stabilization, and an autologous rib cartilage preparation technique designed to minimize long-term warping. We present a quantitative assessment of resultant nasal symmetry and tip projection.
Methods: Thirty five patients with unilateral cleft lip and palate who underwent secondary cleft rhinoplasty using a caudal septal extension graft and circumferential support of the cleft sided ala will be included. Standardized photographs taken pre-operatively and an average of 20.54 months (range 11-60 months) post-operatively were used to compare tip projection and ratios of cleft side to non-cleft side nostril height, width, and area. Wilcoxon signed-rank test evaluated statistically significant differences between the measurements. Intra-rater and inter-rater reliability were measured using two-way mixed-effects and random-effects intraclass correlation coefficient (ICC) models for absolute agreement, respectively.
Results: To date results from 13 of 35 patients with a mean age of 23.31 ± 3.47 years have been analyzed. Six patients (46.15%) were male and 7 patients (53.85%) were female. 8 patients (61.54%) had left-sided cleft lip and palate. Intra-rater and inter-rater reliability were good to excellent across variables with intra-rater ICCs ranging from 0.86 to 0.99 (mean ICC 0.95 (rater 1) and 0.97 (rater 2)) and inter-rater ICCs ranging from 0.81 to 0.99 (mean ICC 0.92). From the preoperative to postoperative period, tip projection, represented as a ratio of subnasale-pronasale over inter-alar width significantly improved by 14.2% (p<0.01). Nostril width symmetry (ratio of cleft side width over non-cleft side width) significantly improved by 30.1% (p=0.03). Nostril area symmetry (ratio of cleft side nostril area over non-cleft side nostril area) demonstrated a non-significant trend towards improvement by 29.1% (p=0.09). Nostril height symmetry (ratio of cleft side height over non-cleft side height) showed no significant change (p=0.38). 4 patients experienced complications requiring revision surgery, including nasal synechiae (n=1), migration of caudal septum (n=1) and migration/loss of septal extension graft (n=2).
Conclusions: Using a boney anchored caudal septal extension graft harvested from the 6th 7th intercostal bridge and circumferential support of the cleft ala appears a promising approach to stable secondary cleft rhinoplasty that can improve nostril width symmetry and tip projection with possible optimization of nostril area symmetry. Updated results will be presented.
|
5:25 PM
|
A Deeper Dive into The Structure of Fat: Systemic and Depot-Specific Determinants of Adipose Tissue Architecture
Purpose: Adipose tissue exhibits biological heterogeneity, yet the relative contributions of systemic factors such as BMI and age versus intrinsic depot-specific properties remain unclear. Prior work has largely focused on obesity-related changes in subcutaneous and visceral depots, but how adipocyte morphology and extracellular matrix (ECM) composition vary across anatomical sites and whether these structural differences are systemically driven or locally regulated is poorly understood. Importantly, distinguishing these drivers is critical for understanding depot-specific behavior in aging, metabolic disease, and reconstructive applications. This study aimed to distinguish systemic from depot-specific determinants of adipose microarchitecture by analyzing adipocyte size and ECM fraction across multiple tissue sources while adjusting for BMI and age.
Methods: Adipose tissue was collected from patients undergoing breast reduction, mastectomy, abdominoplasty, blepharoplasty, and lipoma excision (n=234). Histologic sections were quantified for cross-sectional adipocyte area (µm²) and ECM fraction (matrix %) using ImageJ. Patient demographics, including BMI, age and sex were recorded. Multivariable ANCOVA was used to assess the independent effects of systemic factors and tissue source. Interaction terms (age × depot) were evaluated to determine whether aging-related remodeling differed by anatomical site.
Results: Adipocyte size was predominantly systemically regulated. BMI demonstrated the strongest independent association (β=35.9 µm² per BMI unit, p<0.001), and age also contributed significantly (β=6.8 µm² per year, p=0.009). After adjustment for BMI and age, tissue source did not significantly influence adipocyte size, indicating that hypertrophy is largely driven by systemic metabolic factors rather than intrinsic depot identity. In contrast, ECM fraction was strongly depot-specific (overall R²=0.425, p<0.001) and independent of BMI and age. Periorbital adipose samples collected from blepharoplasty exhibited the highest matrix fraction (8.14 ± 3.19%), whereas breast reduction (3.71 ± 1.33%) and abdominal depots (3.96 ± 1.29%) demonstrated substantially lower ECM content. Mastectomy tissue showed intermediate but more variable ECM levels (5.33 ± 3.63%). Age alone did not significantly affect ECM composition. Interaction analysis revealed that aging-related ECM remodeling occurred selectively in breast tissue collected from mastectomy (age × depot, p=0.032), whereas periorbital, breast and abdominal depots remained structurally stable across age groups. Sex was not an independent determinant of adipocyte size or ECM fraction.
Conclusions: Adipocyte hypertrophy is primarily systemically driven by BMI and age, whereas ECM composition reflects intrinsic depot-specific structural identity. Most depots demonstrate remarkable ECM stability across the age span, with selective age-associated ECM decreased fraction observed only in oncologic breast tissue. These findings delineate distinct systemic and local determinants of adipose architecture and provide a structural framework for understanding adipose heterogeneity. Such insights have important implications for fat grafting, regenerative strategies, and interpretation of depot-specific aging or disease-related remodeling. This helps improve our understanding of why adipose depots respond differently to metabolic stress and aging. Furthermore, these data suggest that adipose tissue remodeling cannot be inferred solely from systemic metabolic status but must be interpreted within a depot-specific context.
|
5:30 PM
|
Microcomputed Tomography (Micro-CT) Mapping of Corrugator Supercilii and Procerus Anatomy: Implications for Procedures Involving the Glabella Musculature
Background:
A detailed understanding of the glabella musculature is essential for performing safe and effective chemodenervation, forehead rejuvenation surgery, and migraine trigger-site nerve decompression. Most existing studies focus primarily on defining surface anatomy rather than three-dimensional (3D) parameters. Additionally, previous studies obtained measurements using cadaver dissection, where dissection has the potential to distort the native regional anatomy. In this study, the authors employed advanced imaging technology to analyze the multi-dimensional characteristics of the corrugator supercilii and procerus muscles, including their relationships to key facial landmarks, depth beneath the skin across regions, and variations in muscle thickness.
Methods:
Ten adult cadavers – 5 male, 5 female – were analyzed using high-resolution micro–computed tomography (micro-CT) to obtain precise 3D measurements of the glabella musculature. An advanced specimen staining protocol using triple 9% iodine was utilized to improve visualization of the procerus and corrugators. Corrugator depth from skin and thickness were measured bilaterally at the medial canthus (MC), midpupil (MP), and lateral limbus (LL), as well as the distance from the muscle's medial origin and lateral apex to the bony landmarks of the nasion and lateral orbital rim. Procerus depth from skin and thickness were measured at the superior, inferior, and most central aspect of the muscle. Regional differences were assessed by paired t-tests. Sex-based comparisons were performed using independent t-tests.
Results:
Corrugator musculature was symmetric, as comparisons between left- and right-sided measurements did not reveal significant asymmetries (p > 0.05). Corrugator depth from skin decreased from 3.82 mm at the MC, to 3.41 mm at the MP, to 2.69 mm at the LL (-1.13 mm, p = 0.002). Corrugator thickness paralleled this pattern, decreasing from 1.52 mm at the MC, to 1.28 mm at the MP, to 0.95 mm at the LC (-0.57, p < 0.001). Procerus thickness inferiorly (0.87 mm) was thinner than both centrally (1.38 mm, p = 0.020) and superiorly (1.34, p = 0.006); central and superior aspects were equivalent (p = 0.77). Sex-based comparisons revealed no significant differences (all p > 0.05).
Conclusions:
This study used high-resolution micro-CT technology to map the 3D structure and topography of the corrugator supercilii and procerus muscles without tissue distortion inherent in gross dissection, building upon the established literature. The corrugator becomes progressively thinner and more superficial laterally, while the procerus demonstrates relative inferior attenuation. Knowledge of these relationships can enhance surgical safety and efficacy by improving precision during injections and operations at the glabella.
|
5:35 PM
|
Scientific Abstract Presentations: Abstract Topics Session 2: Discussion 1
|
5:35 PM
|
The Durability Of Novosorb Biodegradable Temporizing Matrix To Radiotherapy In Head And Neck Skin Cancer: An Update And Retrospective Analysis Of 22 Patients
Background
Biodegradable Temporizing Matrix (BTM) is increasingly utilized for reconstruction of complex cutaneous defects following oncological resection (1). However, the impact of radiotherapy on BTM integration and wound healing remains poorly characterized. This study evaluates the resilience of BTM to radiotherapy, focusing on healing outcomes, breakdown rates, and reconstruction success.
Methods
A retrospective analysis of 295 patients who underwent BTM reconstruction between September 2020 to February 2026 was performed. Of these, 252 were for reconstruction following cutaneous malignancy excision, with 143 in the head and neck region. 22 patients, all of whom had cutaneous malignancies in the head and neck region, received radiotherapy following BTM reconstruction (8.7% of all malignancies, 15.4% of head and neck cases). Primary outcomes included BTM breakdown, time to healing, and graft take rates. Secondary reconstruction methods included split-thickness skin graft (SSG), full-thickness skin graft (FTSG), and secondary intention healing.
Results
Data pertaining to 22 patients were collected with a median follow-up of 23 months (range 8-57). 18 patients had adjuvant radiotherapy, 4 had prior radiotherapy to the area operated upon. Median age was 76 years (range 32-91). The majority of tumors were stage 3-4 (95%) with invasion to bone (64%). 4 patients had Mohs micrographic surgery, the remainder had conventional excision.
Overall graft take rate (SSG/FTSG) was 94.4% (17/18). Mean time to secondary reconstruction with skin graft was 55.4 days. In cases where secondary healing was allowed to occur, mean time to healing was 89 days.
Overall BTM integration success was 81.8% (18/22). Breakdown occurred in 4 patients (18.2%), with one case (4.5%) attributable to tumor recurrence. As such, BTM breakdown due to radiotherapy could be considered to have occurred in 3 cases (13.7%). In these three cases, breakdown was noted to have occurred in 2, 25 and 28 months following radiotherapy. All non-recurrence breakdowns occurred on burred calvarium and were successfully managed with local interventions.
Conclusions
This study represents the largest and only series worldwide examining adjuvant radiotherapy following BTM reconstruction. Our findings demonstrate that BTM exhibits acceptable resilience to radiotherapy, with an overall integration success rate of 81.8% and graft take rate of 94.4%. Prior radiotherapy does not appear to impair BTM integration. Clinicians should be aware that breakdown of BTM can occur up to 2 years following radiotherapy. These novel data provide important guidance for the management of patients requiring both BTM reconstruction and adjuvant radiotherapy for advanced cutaneous malignancies.
References
Conway L, Snashall E, Gill P, Harper-Machin A. The Use of Novosorb Biodegradable Temporizing Matrix for Reconstruction in Head and Neck Cancer: A Simple Answer to a Complex Problem. Plast Reconstr Surg Glob Open. 2025;13(4):e6702.
|
5:40 PM
|
The Value of Cortical Burring In Cutaneous Squamous Cell Carcinoma of the Head and Neck With Narrow or Involved Deep Margins – A Series of 200 Patients at a Regional Plastic Surgery Centre
Background
Primary cutaneous squamous cell carcinoma (cSCC) of the head and neck with close or involved deep excision margins carries high risk of recurrence, necessitating adjuvant radiotherapy or bone burring and subsequent reconstruction. Minimal work has been published examining the efficacy of burring. We describe a cohort of such patients and assess their recurrence rate.
Methods
Retrospective chart review to obtain patient demographics and tumour characteristics. Patients with primary disease only with either close (<1mm) or involved deep excision margin at their initial operation were included. Patients had been managed with burring, radiotherapy or observation alone. Logistic regression was used to examine the association between burring and recurrence, reported as odds ratio (OR) with 95% confidence intervals (95% CI).
Results
Data for 200 patients were collected. 167 were male (83.5%), mean age of cohort 81 years (SD 8.51). Burring was done in 112 patients (56%), of which 12 had radiotherapy. Radiotherapy was the sole modality in 39 patients (19.5%) and observation alone in 49 (24.5%). In burred patients, 9 developed local recurrence or new nodal disease (8%). This is lower than rates demonstrated in other case series (11.8-50%). In patients that received radiotherapy alone, incidence of recurrence was seen in 6 cases (11.8%) and in patients that had no intervention, recurrence was observed in 8 cases (16.3%).
In logistic regression models, burring is strongly inversely associated with local disease recurrence (OR 0.24, 95% CI 0.06-0.90). This was statistically significant (p=0.03), following multivariate adjustment for age, sex, radiotherapy, tumour characteristics, perineural invasion and staging.
Conclusion
Our results demonstrate that outer table bone burring appears to be strongly protective against local SCC disease recurrence in the head and neck, with a significant inverse association. As such it should be considered as a primary treatment modality in patients with close/involved deep margins, offering robust local disease control and deep margin management. Our approach appears to have lower recurrence rates than other reported series, perhaps due to our extensive use of burring, however prior series have been limited in their scope.
|